Kewaunee Scientific (NASDAQ:KEQU) Stock Price Passes Above Two Hundred Day Moving Average - What's Next?

Shares of Kewaunee Scientific Co. (NASDAQ:KEQU - Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $42.85 and traded as high as $63.23. Kewaunee Scientific shares last traded at $61.10, with a volume of 53,912 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded Kewaunee Scientific from a "hold" rating to a "buy" rating in a research note on Wednesday, December 18th.

Kewaunee Scientific Stock Up 4.1 %

The firm's fifty day simple moving average is $41.35 and its 200 day simple moving average is $42.98. The company has a current ratio of 2.53, a quick ratio of 2.00 and a debt-to-equity ratio of 0.48. The company has a market cap of $182.72 million, a price-to-earnings ratio of 10.08 and a beta of 0.80.

Insider Transactions at Kewaunee Scientific

In other news, CFO Donald T. Gardner III sold 2,049 shares of the company's stock in a transaction dated Tuesday, December 24th. The shares were sold at an average price of $58.19, for a total value of $119,231.31. Following the completion of the sale, the chief financial officer now directly owns 22,615 shares of the company's stock, valued at approximately $1,315,966.85. This represents a 8.31 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Elizabeth D. Phillips sold 1,850 shares of the company's stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $54.17, for a total value of $100,214.50. Following the sale, the vice president now directly owns 13,591 shares of the company's stock, valued at approximately $736,224.47. This represents a 11.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 14.20% of the company's stock.

Institutional Investors Weigh In On Kewaunee Scientific

Large investors have recently modified their holdings of the stock. JPMorgan Chase & Co. raised its position in Kewaunee Scientific by 18,000.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company's stock worth $30,000 after buying an additional 900 shares during the last quarter. Barclays PLC purchased a new position in Kewaunee Scientific in the third quarter valued at about $121,000. Heron Bay Capital Management purchased a new stake in shares of Kewaunee Scientific in the 2nd quarter worth about $252,000. State Street Corp acquired a new stake in Kewaunee Scientific during the 3rd quarter valued at $266,000. Finally, Ritholtz Wealth Management acquired a new stake in shares of Kewaunee Scientific during the second quarter worth $413,000. Hedge funds and other institutional investors own 32.69% of the company's stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.